Beckman Coulter is proud to be exhibiting at the IBMS Congress 2025, a particularly special year as it celebrates its 90th anniversary. Visit stand 608, where Beckman Coulter will be showcasing its latest innovations designed to advance laboratory efficiency and diagnostic accuracy.
A key highlight of the stand will be the DxI 9000 Immunoassay Analyser. Following its official UK launch at the 2023 Congress, the 2025 event marks a two-year milestone - the perfect opportunity to share its impact and how it continues to evolve to meet the current and future needs of clinical laboratories. Notably, the DxI 9000 Analyser has seen significant menu expansion. Over the past two years, Beckman Coulter has introduced more than 62 new assays for use on the DxI 9000 Analyser, including tests for anaemia, cardiac care, diabetes, infectious diseases, reproductive health, and sepsis, to name just a few.
Additionally, the DxH 900 Workcell will be present at Congress, which is now integrated with Scopio Labs. This enables the capture of large scan areas at 100x magnification, virtually eliminating the need for additional manual microscopic examination.
The company’s team of experts will be on hand to provide live demonstrations, answer questions, and discuss how Beckman Coulter’s technologies can support your laboratory’s goals. Whether you're looking to streamline operations, improve turnaround times, or enhance diagnostic confidence, Beckman Coulter’s solutions are designed to meet your specific needs.